Ascendis Pharma (ASND) Reports Q3 Loss of EUR1.04
Ascendis Pharma (NASDAQ: ASND) reported Q3 EPS of (EUR1.04), versus (EUR0.72) reported last year.
For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.
Ascendis Pharma (NASDAQ: ASND) reported Q3 EPS of (EUR1.04), versus (EUR0.72) reported last year.
For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.